1921
Volume 74, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Human T-cell lymphotropic virus type-II (HTLV-II) infection is endemic in indigenous groups in the Americas and injection drug users (IDUs) worldwide. In Peru, HTLV-II infection was previously identified in two indigenous Amazonians. We examined risk factors for HTLV-II infection in 2,703 Peruvian men who have sex with men (MSM): 35 (1.3%) were HTLV-II positive. HTLV-II infection was associated with syphilis, HSV-2 infection, unprotected receptive anal intercourse, and older age. This is the first report of HTLV-II in a non-indigenous non-IDU population in Peru. Additional studies are needed to determine if HTLV-II is a sexually transmitted infection in this and other sexually active populations.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2006.74.922
2006-05-01
2017-11-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/74/5/0740922.html?itemId=/content/journals/10.4269/ajtmh.2006.74.922&mimeType=html&fmt=ahah

References

  1. Lal RB, Gongora-Biachi RA, Pardi D, Switzer WM, Goldman I, Lal AF, 1993. Evidence for mother-to-child transmission of human T lymphotropic virus type II. J Infect Dis 168 : 586–591.
  2. Maloney EM, Armien B, Gracia F, Castillo L, Kruger H, Levin A, Levin PH, Kaplan JE, Blattner WA, Giusti RM, 1999. Risk factors for human T cell lymphotropic virus type II infection among the Guaymi Indians of Panama. J Infect Dis 180 : 876–879.
  3. Proietti F, Proietti AB, Catalan-Soares B, 2003. Heterogeneous geographical distribution of HTLV-I/II serologic screening prevalence rates in blood donors from large urban areas in Brazil. AIDS Res Hum Retrovirol 19 : S33–S34.
  4. Ferrer JF, Del Pino N, Esteban E, Sherman MP, Dube S, Dube DR, Basombrio MA, Pimentel E, Segovia A, Quirulas S, et al., 1993. High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology 197 : 576–584.
  5. Medeot S, Nates S, Recalde A, Gallego S, Maturano E, Giordano M, Serra H, Reategui J, Cabezas C, 1999. Prevalence of antibody to human T cell lymphotropic virus types 1/2 among aboriginal groups inhabiting northern Argentina and the Amazon region of Peru. Am J Trop Med Hyg 60 : 623–629.
  6. Zurita S, Costa C, Watts D, Indacochea S, Campos P, Sanchez J, Gotuzzo E, 1997. Prevalence of human retroviral infection in Quillabamba and Cuzco, Peru: a new endemic area for human T cell lymphotropic virus type 1. Am J Trop Med Hyg 56 : 561–565.
  7. Sanchez-Palacios C, Gotuzzo E, Vandamme AM, Maldonado Y, 2003. Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women. Int J Infect Dis 7 : 132–137.
  8. Trujillo L, Munoz D, Gotuzzo E, Yi A, Watts DM, 1999. Sexual practices and prevalence of HIV, HTLV-I/II, and Treponema pallidum among clandestine female sex workers in Lima, Peru. Sex Transm Dis 26 : 115–118.
  9. Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, Heneine W, Wright D, Matijas L, Thomson R, Rudolph D, Kleinman S, Busch M, Schreiber GB, 1996. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 12 : 193–201.
  10. Roucoux DF, Wang B, Smith D, Nass CC, Smith J, Hutching ST, Newman B, Lee TH, Chafets DM, Murphy EL, HTLV Outcomes Study Investigators, 2005. A prospective study of sexual transmission of human T lymphotropic virus (HTLV)-I and HTLV-II. J Infect Dis 191 : 1490–1497.
  11. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE, 1992. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 326 : 375–380.
  12. Feigal E, Murphy E, Vranizan K, Bacchetti P, Chaisson R, Drummond JE, Blattner W, McGrath M, Greenspan J, Moss A, 1991. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J Infect Dis 164 : 36–42.
  13. Schwebke J, Calsyn D, Shriver K, Saxon A, Kleyn J, Oluoch-Mitchell E, Olmstead L, Fisher LD, Krone M, Ashley R, et al., 1994. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users. J Infect Dis 169 : 962–967.
  14. Thiede H, Harris NV, McGough JP, Roberts B, Khabbaz RF, Kaplan JE, 1994. Prevalence of HTLV types I and II among drug users in King County, Washington. West J Med 160 : 540–544.
  15. Gotuzzo E, Sanchez J, Escamilla J, Carrillo C, Phillips IA, Moreyra L, Stamm W, Ashley R, Roggen EL, Kreiss J, et al., 1994. Human T cell lymphotropic virus type I infection among female sex workers in Peru. J Infect Dis 169 : 754–759.
  16. Zunt JR, La Rosa A, Lama JR, Sanchez J, 2004. HTLV-I and -II in high risk populations in Peru. 53rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Miami Beach, FL, November 7–11, 2004.
  17. Murphy EL, Gibbs WN, Figueroa JP, Bain B, LaGrenade L, Cranston B, Blattner WA, 1988. Human immunodeficiency virus and human T-lymphotropic virus type I infection among homosexual men in Kingston, Jamaica. J Acquir Immune Defic Syndr 1 : 143–149.
  18. Meyer RD, Moudgil T, Detels R, Phair JP, Hirsch MS, Ho DD, 1990. Seroprevalence of human T cell leukemia viruses in selected populations of homosexual men. J Infect Dis 162 : 1370–1372.
  19. Bartholomew C, Saxinger WC, Clark JW, Gail M, Dudgeon A, Mahabir B, Hull-Drysdale B, Cleghorn F, Gallo RC, Blattner WA, 1987. Transmission of HTLV-I and HIV among homosexual men in Trinidad. JAMA 257 : 2604–2608.
  20. Maldonado MG, Guzman G, Valverde A, Gail M, Dudgeon A, Mahabir B, Hull-Drysdale B, Cleghorn F, Gallo RC, Blattner WA, 2005. Seroprevalence and epidemiological characteristics of human T-lymphotropic virus type I among sex workers in the city of Iquitos between April 2003 and January 2004. 54th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington, DC, December 11–15, 2005.
  21. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW, 2002. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 29 : 38–43.
  22. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP, 1999. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 150 : 306–311.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2006.74.922
Loading
/content/journals/10.4269/ajtmh.2006.74.922
Loading

Data & Media loading...

  • Received : 01 Nov 2005
  • Accepted : 11 Jan 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error